DelveInsight launched a new report on Germany Healthcare Outlook Report 2020.
DelveInsight’s, “Germany Healthcare Outlook Report, 2020,” report provides comprehensive insights about healthcare scenarios, regulatory policies, and reimbursement landscape in Germany. The report also identifies key trends in the healthcare market and provides insights into the demographic and healthcare infrastructure of the country. Along with this the report also provides a brief look into the trends and segmentation of the pharmaceutical and medical devices market of Germany.
Request for sample pages of the report: https://www.delveinsight.com/sample-request/germany-healthcare-outlook-report
About GERMANY Healthcare Outlook
Germany officially the Federal Republic of Germany is a country in Central and Western Europe with 83.2 million people, distributed on a territory of 357,022 square kilometers. In 2019, GDP growth for Germany was 0.6 %. Germany has a universal multi-payer health care system. It encompasses both statutory health insurance for people who earn less than a certain salary, as well as private health insurance for those who earn more and choose to purchase their own. Health insurance is provided by two subsystems: statutory health insurance (SHI), consisting of competing, not-for-profit, nongovernmental health insurance plans known as sickness funds; and private health insurance. Long-term care services are covered separately under Germany’s mandatory, statutory long-term care insurance (LTCI). Unlike those in many other countries, sickness funds and private health insurers, as well as long-term care insurers, use the same providers. In other words, hospitals and physicians treat all patients regardless of whether they have SHI or private insurance.
GERMANY Market Access
The market access section of the Germany Healthcare Outlook report contains information on how to penetrate the pharmaceutical and medical device markets in terms of setting up manufacturing unit, import export licensing, regulations pertaining to patents, trademarks, clinical trials, advertising, pharmacy regulation, labeling and packaging. It also covers detail about healthcare insurance and reimbursement policy.
Table of Contents:
1. Key Insights
2. Germany at a Glance
3. Executive Summary
5. Market Access
6. Germany PESTLE Analysis
7. Driver and Barriers
10. DelveInsight Capabilities
12. About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States